Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions.
about
Expression and Functional Characterization of the BNIP3 Protein in Renal Cell Carcinomas.Novel combination strategies for enhancing efficacy of immune checkpoint inhibitors in the treatment of metastatic solid malignancies.PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas.T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection.Genomics of adult and pediatric solid tumorsThe Identification of Immunological Biomarkers in Kidney CancersComparable immunoreactivity rates of PD-L1 in archival and recent specimens from non-small cell lung cancer
P2860
Q41695085-4EB894C0-910E-4976-9717-C264922419DDQ47936526-BE81DDA7-E44C-4258-B7A5-6FF000018B68Q50056734-0A95AC82-D798-4759-8F71-ACBC2A105CAFQ52593234-08BE000B-34FF-4EBE-8AAD-BE3677E6C65DQ55418935-37B00D6D-12C5-4DB6-9D88-376B54D2C1F5Q58804574-D14545E1-DCEE-4064-956C-FB3AA5BFA5B8Q59132089-3C59FB73-3343-45F2-AC26-6D2BDB978C41Q59132351-2C2F5237-7FA2-492A-9DD2-33713E269ED3
P2860
Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Immune checkpoint inhibitors i ...... to date and future directions.
@en
type
label
Immune checkpoint inhibitors i ...... to date and future directions.
@en
prefLabel
Immune checkpoint inhibitors i ...... to date and future directions.
@en
P2093
P2860
P356
P1433
P1476
Immune checkpoint inhibitors i ...... to date and future directions.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDX151
P577
2017-04-05T00:00:00Z